FDA Will Consider OK'ing COVID-19 Vaccine Before End Of Phase 3 Trials

The transcript discusses the potential for the FDA to issue an Emergency Use Authorization (EUA) for COVID-19 vaccines, allowing distribution before phase three trials are complete. It highlights concerns from the American Medical Association about rushing the process and addresses political claims by President Trump that the FDA is delaying vaccine development. The transcript also covers public hesitancy towards vaccines, with a Gallup poll indicating that 35% of Americans would not take a free FDA-approved vaccine. Finally, it provides an update on the status of current vaccine trials in the U.S.

What did President Donald Trump claim about the FDA's role in vaccine development?

What are the implications of rushing the vaccine approval process according to health officials?